Brightsurf Science News & Current Events

June 01, 2013
ATS publishes clinical practice guidelines on sleep apnea and driving
The American Thoracic Society has released new clinical practice guidelines on sleep apnea, sleepiness, and driving risk on non-commercial drivers.

When to start (and not stop) resuscitation efforts
One of the most difficult moments faced by anaesthetists and other healthcare staff is when to carry on attempts to resuscitate a person, and when those efforts should reasonably stop.

Enhanced white blood cells heal mice with MS-like disease
Genetically engineered immune cells seem to promote healing in mice infected with a neurological disease similar to multiple sclerosis, cleaning up lesions and allowing the mice to regain use of their legs and tails.

New drug improves progression-free survival, shrinks tumors in rare cancer for first time
The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented on Saturday, June 1, at the 49th annual meeting of the American Society of Clinical Oncology.

Study finds glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life
Many glioblastoma patients treated with bevacizumab (AvastinĀ®) have significant deterioration in neurocognitive function, symptoms and quality of life.

Major new initiative for patient safety in Europe unveiled
A major new initiative for patient safety in Europe is today launched by Professor Eberhard Kochs, President of the European Society of Anaesthesiology (ESA).

Osteoporosis drug aids young people with cystic fibrosis not helped by standard treatments
The first randomised trial to investigate the treatment of low bone density in young people with cystic fibrosis (CF), published Online First in The Lancet Respiratory Medicine, provides compelling evidence that alendronate (a drug that curbs bone loss) is safe and can help increase bone mineral density in young patients with CF after standard treatment with calcium and vitamin D has failed.

Targeted therapy boosts lung cancer outcomes
Non-small cell lung cancer patients whose tumor cells had an abnormal ALK gene fared better if treated with crizotinib, a targeted therapy, than with traditional chemotherapy.

ATS publishes clinical practice guidelines on sleep apnea and driving
The American Thoracic Society has released new clinical practice guidelines on sleep apnea, sleepiness, and driving risk on non-commercial drivers.

Cytomegalovirus might speed brain-cancer growth
Cytomegalovirus (CMV) infects most middle-aged Americans but usually remains dormant in the body.

MGH-led studies shed new light on targeted lung cancer therapy
Research teams led by Massachusetts General Hospital Cancer Center investigators are publishing two important studies regarding use of the targeted cancer drug crizotinib for treatment of advanced lung cancer driven by specific genetic mutations.

Spousal oral HPV, predictors of melanoma and throat cancer, preventing cancer readmissions
Mount Sinai researchers will present several studies at the 2013 ASCO meeting May 31-June 4, 2013, in Chicago, including data on the likelihood of spousal human papillomavirus oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery.

UK doctors and nurses that are injured while treating unconscious patients cannot test them for HIV due to lack of legal protection, while in most of Europe such testing is permitted
Doctors and nurses in the UK that are injured in the course of treating injured patients cannot currently test that patient for HIV without their consent.

No increased risk of infection for long-term sex partners of people with HPV-related oral cancers
Spouses and long-term partners of patients with mouth and throat cancers related to infection with the human papilloma virus (HPV) appear to have no increased prevalence of oral HPV infections, according to results of a multicenter, pilot study led by Johns Hopkins investigators.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.